Furthermore, we did not observe any significant association of basal circulating chemerin levels with the extent of obesity and with common metabolic comorbidities such as T2D, hypertension, hyperlipidemia, and markers of hepatic fibrosis. This evidence concerns the gene RARRES2 and type 2 diabetes mellitus.